Health News
Stay informed with the latest health industry news from around the globe. Read about advancements in health technology, updates in health insurance, innovations in medical devices, and more. Keep up with important health trends and industry developments.
Mar 25, 2025 at 6:39 AM
Maria Grice Named COO of Associated Medical Professionals of NY, an Affiliate of U.S. Urology Partners
SYRACUSE, N.Y.--(BUSINESS WIRE)--Grice tapped to lead operations of U.S. Urology Partners affiliate Associated Medical Professionals of NY with services throughout Central New York...
Mar 25, 2025 at 6:30 AM
Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates
HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2024 financial results and recent corporate updates. “In 2024, we reached key milestones that reinforced our financial foundation, expanded our leadership team, and advanced our clinical pipeline, highlighting our commitment to establishing a le...
Mar 25, 2025 at 6:00 AM
TOLREMO Strengthens Scientific Advisory Board with Lung Cancer Expert Pasi A. Jänne
BASEL, Switzerland--(BUSINESS WIRE)--TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Pasi A. Jänne, M.D., PhD, a world renowned translational thoracic medical oncologist, to its Scientific Advisory Board (SAB). Professor Jänne is one of the global leaders in the treatment of drug-resistant lung cancer and will be an important contributor to further TOLREMO’s goal of preventing non-genetic cancer drug resistance. The company’s lead candidate, TT125-802, is a novel small mole...
Mar 25, 2025 at 6:00 AM
ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American College of Cardiology (ACC) 74th Annual Scientific Session & Expo 2025, taking place in Chicago, IL, from March 29-31, 2025. Ten presentations will feature new data from the pivotal Phase III FINEARTS-HF cardiovascular (CV) outcomes trial, which investigated KERENDIA for the treatment of adult pati...
Mar 25, 2025 at 6:00 AM
SOLVE FSHD Announces Strategic Collaboration with Transcripta Bio to Advance Drug Discovery for FSHD
VANCOUVER, British Columbia--(BUSINESS WIRE)--SOLVE FSHD, a venture philanthropy organization dedicated to accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD), is pleased to announce a strategic collaboration with Transcripta Bio, a cutting-edge AI-driven drug discovery company. This collaboration will focus on leveraging Transcripta Bio’s advanced drug screening platform to identify and develop promising therapeutic candidates for FSHD, a debilitating muscular disorder af...
Mar 25, 2025 at 5:36 AM
WHO Foundation and L’Oréal Groupe Unite to Improve Skin Health Worldwide
GENEVA--(BUSINESS WIRE)--The WHO Foundation and the L’Oréal Groupe, spearheaded by its Dermatological Beauty Division, are set to launch a four-year partnership to expand access to the treatment of skin conditions worldwide. With a focus on low- and middle-income settings, the partnership will accelerate the World Health Organization’s (WHO’s) efforts to support countries to address skin conditions such as those caused by neglected tropical diseases (NTDs), those exacerbated by climate change a...
Mar 25, 2025 at 4:00 AM
Citi Appointed as Depositary Bank for Nightingale Health OYJ’s ADR Program
LONDON--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank N.A., has been appointed by Nightingale Health OYJ (“Nightingale Health”) to act as depositary bank for its sponsored Level 1 American Depositary Receipt (“ADR”) program. Nightingale Health’s ADRs are traded on the OTCQX platform under the symbol “NHLTY”. Each ADR represents one ordinary share of the company. Nightingale Health’s underlying ordinary shares are listed and traded on the Nasdaq Helsinki Stock Exchange under the...
Mar 25, 2025 at 4:00 AM
3D Investment Publishes Corporate Value Enhancement Plan for Toho Holdings
TOKYO--(BUSINESS WIRE)--3D Investment Partners Pte. Ltd. (“3D” or “we”), the investment manager of the 3D OPPORTUNITY MASTER FUND, today, published a presentation provided to Toho Holdings Co., Ltd. (“Toho HD” or the “Company”) (8129.T) highlighting its proposals to improve Toho HD’s performance and value. 3D has invested in Toho HD since 2020 and is currently one of the Company’s largest shareholders, holding approximately 22%1 of the Company’s voting rights. We have been engaging constructive...
Mar 25, 2025 at 2:00 AM
Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference
MARSEILLE, France--(BUSINESS WIRE)--Innate Pharma announces its participation in the Life Sciences Van Lanschot Kempen Conference...
Mar 25, 2025 at 1:58 AM
Ant Group Unveils Major Upgrades to Its Full-Suite AI Solutions in Healthcare for Hospitals, Doctors and Users
HANGZHOU, China--(BUSINESS WIRE)--Ant Group has announced major upgrades to its comprehensive suite of AI solutions for the healthcare sector, aiming to enhance the capabilities of hospitals and doctors, and collaboratively benefit users through advanced AI innovations. Empowering Hospitals with Secure and Efficient AI Integration As industries increasingly adopt AI technologies, hospitals are leveraging latest innovations, including large models, to streamline operations and enhance patient ca...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.